Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation-Reference-Cited by-同舟云学术

Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation

Published:2021-11 Issue: Volume:520 Page:201-212
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Song Heyu,Xi Shaoyan,Chen Yingling,Pramanik Suravi,Zeng Jiping,Roychoudhury Shrabasti,Harris Hannah,Akbar Anum^ORCID,Elhag Salma S.,Coulter Donald W.,Ray Sutapa,Bhakat Kishor K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Molecular subgroups of medulloblastoma: the current consensus;Taylor;Acta Neuropathol.,2012

2. Intertumoral heterogeneity within medulloblastoma subgroups;Cavalli;Canc. Cell,2017

3. Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: a report from the childhood cancer survivor study;Salloum;J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol.,2019

4. Direct cellular responses to platinum-induced DNA damage;Jung;Chem. Rev.,2007

5. Human apurinic/apyrimidinic endonuclease 1;Li;Antioxidants Redox Signal.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair;Journal of Neuro-Oncology;2024-09-09

2. FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair;2024-09-09

3. Predicting response to chemotherapy in brain tumor patients based on MRI features;Clinical Neurology and Neurosurgery;2024-09

4. Exploiting the DNA Damage Response for Prostate Cancer Therapy;Cancers;2023-12-23

5. Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy;Journal of Experimental & Clinical Cancer Research;2023-11-16